An HbA1c of 7% (53 mmol/mol) is a clinically important result that falls within the diabetic range under UK diagnostic criteria. HbA1c, or glycated haemoglobin, reflects your average blood glucose over the preceding two to three months, making it a key tool for both diagnosing and monitoring diabetes. Whether you have received this result for the first time or are tracking an existing condition, understanding what 53 mmol/mol means — and what steps to take next — is essential. This article explains the diagnostic thresholds, NICE targets, and practical actions to discuss with your GP or diabetes care team.

What an HbA1c Result of 7% (53 mmol/mol) Means

An HbA1c of 53 mmol/mol (7%) falls within the diabetic range in the UK, as any result at or above 48 mmol/mol (6.5%) indicates diabetes. It also represents the upper NICE target for type 2 diabetes patients on hypoglycaemia-risk medicines.

An HbA1c result of 7% — equivalent to 53 mmol/mol in the units used across the UK — is a clinically significant value that sits within the range used to diagnose and monitor diabetes. HbA1c, or glycated haemoglobin, reflects your average blood glucose levels over the preceding two to three months. When glucose circulates in the bloodstream, it binds to haemoglobin within red blood cells; the higher the blood glucose, the greater the proportion of glycated haemoglobin.

To understand where 53 mmol/mol sits, it helps to know the main diagnostic bands used in the UK:

• Below 42 mmol/mol (6.0%) — within the normal range

• 42–47 mmol/mol (6.0–6.4%) — non-diabetic hyperglycaemia (sometimes called prediabetes), indicating an elevated risk of developing diabetes

• 48 mmol/mol (6.5%) or above — indicates diabetes (type is determined by clinical assessment, not by HbA1c alone)

A result of 53 mmol/mol therefore falls within the diabetic range. For adults with type 2 diabetes already on treatment, 53 mmol/mol represents the upper end of the NICE target range — specifically for those on medicines that carry a risk of hypoglycaemia, or where a less stringent target is clinically appropriate. For those managed by lifestyle changes alone or with metformin only, the usual NICE target is 48 mmol/mol (6.5%).

This figure is not a standalone verdict — it is one piece of clinical information interpreted alongside your individual health history, risk factors, medicines, and overall wellbeing. Your GP or diabetes care team will discuss what this result means for you specifically.

Note that HbA1c is not suitable for diagnosing diabetes in certain situations, including pregnancy, children and young people, suspected type 1 diabetes, acute illness, and people with certain haemoglobin disorders or other conditions affecting red blood cells. In these circumstances, alternative tests such as fasting plasma glucose or an oral glucose tolerance test (OGTT) are used instead.

How HbA1c Is Measured and Reported in the UK

HbA1c is measured via a venous blood sample in a laboratory and reported in mmol/mol (IFCC units) in the UK since 2011; 7% equals 53 mmol/mol. Conditions such as anaemia, haemoglobin variants, and pregnancy can affect result reliability.

In the United Kingdom, HbA1c is measured through a blood test, typically taken from a vein in the arm at a GP surgery or hospital laboratory. Unlike a finger-prick glucose test, which captures blood sugar at a single moment in time, HbA1c provides a longer-term picture of glycaemic control — generally reflecting the previous 8 to 12 weeks.

The UK transitioned from reporting HbA1c as a percentage (DCCT units) to reporting in mmol/mol (IFCC units) in 2011, following international standardisation. However, many patients and some clinical resources still refer to the percentage figure. The conversion is straightforward:

• 7% = 53 mmol/mol

• 6.5% = 48 mmol/mol

• 7.5% = 58 mmol/mol

For diagnostic purposes, HbA1c must be measured using a laboratory-standardised, IFCC-aligned assay. Point-of-care (finger-prick) HbA1c devices should not be used to diagnose diabetes.

Certain conditions can affect the reliability of HbA1c results. These include:

• Haemoglobin variants (such as sickle cell trait or other haemoglobinopathies)

• Haemolytic anaemia

• Iron deficiency anaemia

• Advanced chronic kidney disease

• Recent blood transfusion

• Vitamin B12 deficiency

• Pregnancy

In these circumstances, HbA1c may not accurately reflect glycaemic control. For diagnosis when HbA1c is unsuitable, fasting plasma glucose or an OGTT should be used instead, in line with WHO and NICE guidance. Fructosamine testing or continuous glucose monitoring (CGM) may be used to monitor glycaemic control (not for diagnosis) in selected patients where HbA1c is unreliable. Your GP or diabetes care team will take these factors into account when interpreting your result.

What This Result Means for Diabetes Diagnosis and Management

A result of 53 mmol/mol confirms a diagnosis of diabetes if supported by a second abnormal test or clear symptoms, and for those already diagnosed with type 2 diabetes it sits at the upper end of the NICE individualised target range. Treatment intensification is considered if HbA1c remains at or above 58 mmol/mol.

In terms of diagnosis, an HbA1c of 48 mmol/mol (6.5%) or above is used to diagnose diabetes in the UK, in line with WHO 2011 guidance and NICE recommendations. The type of diabetes is determined by clinical assessment — not by the HbA1c value alone. A result of 53 mmol/mol therefore falls within the diabetic range.

If you have no symptoms of diabetes, diagnosis requires two separate abnormal results (either two HbA1c tests, or one HbA1c plus one plasma glucose test). If you do have clear symptoms of diabetes (such as excessive thirst, frequent urination, or unexplained weight loss), a single abnormal result may be sufficient to confirm the diagnosis.

HbA1c should not be used for diagnosis in pregnancy, children and young people, suspected type 1 diabetes, acute illness, or in people with conditions that affect red blood cell turnover or haemoglobin structure. In these situations, fasting plasma glucose or an OGTT should be used.

For those already living with type 2 diabetes, an HbA1c of 53 mmol/mol represents the upper end of the individualised target range recommended by NICE (NG28). It suggests that blood glucose is being managed, but there may be room for improvement. NICE advises considering treatment intensification if HbA1c remains persistently at or above 58 mmol/mol (7.5%) despite current management.

For people with type 1 diabetes, NICE (NG17) recommends an HbA1c target of 48 mmol/mol (6.5%) for adults, meaning a result of 53 mmol/mol may indicate that glycaemic control needs to be reviewed. Management decisions in type 1 diabetes are more complex and typically involve specialist input.

It is also important to recognise that lower is not always better. Overly aggressive glucose-lowering — particularly in older adults, those with cardiovascular disease, or individuals prone to hypoglycaemia — can carry its own risks. Targets are therefore personalised, and a result of 53 mmol/mol may be entirely appropriate for certain individuals.

NICE Guidelines on Target HbA1c Levels for Adults

NICE NG28 recommends 48 mmol/mol (6.5%) for type 2 diabetes managed by lifestyle or metformin alone, and 53 mmol/mol (7%) where hypoglycaemia risk exists or a less stringent target is appropriate. NICE NG17 recommends 48 mmol/mol (6.5%) for adults with type 1 diabetes.

NICE provides clear guidance on HbA1c targets for adults with diabetes, outlined in NG28 (type 2 diabetes in adults: management) and NG17 (type 1 diabetes in adults: diagnosis and management). These targets are intended to reduce the long-term risk of diabetes-related complications, including cardiovascular disease, nephropathy, retinopathy, and neuropathy.

For adults with type 2 diabetes (NICE NG28), the recommended targets are:

• 48 mmol/mol (6.5%) for those managed by lifestyle changes alone, or with a single medicine not associated with hypoglycaemia (such as metformin)

• 53 mmol/mol (7%) for those on medicines that carry a risk of hypoglycaemia, or where a less stringent target is clinically appropriate

NICE NG28 also advises that treatment intensification should be considered if HbA1c remains persistently at or above 58 mmol/mol (7.5%) despite current therapy.

For adults with type 1 diabetes (NICE NG17), the recommended HbA1c target is 48 mmol/mol (6.5%), with the acknowledgement that this must be balanced against the risk of hypoglycaemia.

NICE emphasises that targets should be individualised. Factors such as age, frailty, comorbidities, life expectancy, patient preference, and the burden of treatment are all taken into account. For some individuals — for example, older adults with significant comorbidities or those at high risk of hypoglycaemia — a higher HbA1c target may be clinically appropriate to avoid the harms of over-treatment. Your care team will discuss the most suitable target for you as part of shared decision-making.

These guidelines are regularly reviewed, and healthcare professionals are expected to apply them in the context of each individual patient's circumstances.

Steps to Take After Receiving Your HbA1c Result

Key steps include reviewing diet and physical activity, attending a structured diabetes education programme such as DESMOND or DAFNE, and arranging a medicines review with your GP. HbA1c should be rechecked every three to six months until targets are met.

Receiving an HbA1c result of 53 mmol/mol can feel daunting, but it is an opportunity to take informed, constructive action. Whether you have been newly diagnosed or are monitoring an existing condition, there are several practical steps worth considering.

Review your lifestyle habits. Diet and physical activity have a well-established impact on blood glucose levels. A diet lower in refined carbohydrates and added sugars can meaningfully reduce HbA1c over time. UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week, plus muscle-strengthening activities on at least 2 days per week. Even modest increases in activity can make a difference.

Attend your structured education programme. In the UK, people newly diagnosed with type 2 diabetes are typically offered a referral to a structured self-management education programme such as DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) or X-PERT. For type 1 diabetes, DAFNE (Dose Adjustment For Normal Eating) is widely available. These programmes provide evidence-based guidance on managing blood glucose, diet, and lifestyle.

Ask about NHS weight management and remission programmes. If you are living with overweight or obesity alongside type 2 diabetes, your GP may be able to refer you to an NHS weight management service or a structured low-calorie diet programme, which can support significant improvements in HbA1c and, in some cases, diabetes remission.

Review your medicines with your GP or pharmacist. If you are already on glucose-lowering medication, your result may prompt a review of whether your current regimen is optimised. Do not adjust or stop any medicine without professional advice. If you suspect a medicine is causing side effects, you can report this via the MHRA Yellow Card scheme at www.mhra.gov.uk/yellowcard.

Experiencing these side effects? Our pharmacists can help you navigate them →

Monitor your blood glucose at home if advised. Routine self-monitoring of blood glucose (SMBG) is not recommended for everyone with type 2 diabetes. It is most relevant for people on insulin or a sulfonylurea, where there is a risk of hypoglycaemia, or where your care team has specifically advised it. Keep a record of readings to share at your next appointment.

Book a follow-up appointment. HbA1c is typically reviewed every 3 to 6 months when targets are not met, and annually once stable. Ensure you attend these reviews consistently.

When to Speak to Your GP or Diabetes Care Team

Call 999 immediately for symptoms of DKA or HHS; seek same-day assessment for suspected new-onset type 1 diabetes or severe foot infection. Contact your GP for symptoms of hyper- or hypoglycaemia, unexplained weight loss, or if you are pregnant or planning a pregnancy.

Whilst an HbA1c of 53 mmol/mol does not constitute a medical emergency, there are several circumstances in which you should seek medical advice promptly rather than waiting for your next scheduled appointment.

Call 999 or go to your nearest A&E immediately if you or someone else has symptoms that may suggest diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS). These are serious, potentially life-threatening conditions. Warning signs include:

• Markedly elevated blood glucose with ketones in the urine or blood

• Vomiting, severe abdominal pain, or rapid or laboured breathing

• Drowsiness, confusion, or loss of consciousness

Seek same-day urgent assessment (via your GP or NHS 111) if:

• You have symptoms suggesting new-onset type 1 diabetes (rapid onset of excessive thirst, frequent urination, unexplained weight loss, and fatigue), as this requires prompt specialist referral

• You have a severe foot infection, a deep or rapidly worsening wound, or signs of spreading infection in the foot or leg — these carry a higher risk in people with diabetes and require urgent review

Contact your GP or care team if you experience:

• Symptoms of hyperglycaemia (high blood sugar), such as excessive thirst, frequent urination, fatigue, or blurred vision

• Symptoms of hypoglycaemia (low blood sugar), including shakiness, sweating, confusion, or palpitations — particularly if you are on insulin or a sulfonylurea

• Unexplained weight loss, which can sometimes indicate poorly controlled diabetes

• Any new or worsening symptoms that you are concerned may be related to your blood glucose levels

If you are pregnant or planning a pregnancy, speak to your care team as soon as possible. Tighter glycaemic control is essential during this period. NICE (NG3) recommends aiming for an HbA1c below 48 mmol/mol (6.5%) before conception — or ideally below 43 mmol/mol (6.1%) if this is safely achievable. If your HbA1c is above 86 mmol/mol (10%), NICE advises using effective contraception and optimising blood glucose control before attempting to conceive, given the significantly increased risk of complications.

Finally, if you feel overwhelmed or anxious about your diagnosis or result, do not hesitate to raise this with your care team. Diabetes distress is a recognised and common experience, and psychological support — including referral to a diabetes specialist nurse or mental health professional — is available through the NHS. Managing diabetes is a long-term journey, and your care team is there to support you at every stage.

Frequently Asked Questions